Advances in sampling and screening for chlamydia

Jane S. Hocking, Rebecca Guy, Jennifer Walker, Sepehr N. Tabrizi*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

21 Citations (Scopus)


Chlamydia is the most commonly diagnosed bacterial sexually transmitted infection in the developed world, with diagnosis rates continuing to increase each year. As chlamydia is largely asymptomatic, screening and treatment is the main way to detect cases and reduce transmission. Recent advances in self-collected specimens and laboratory tests has made chlamydia screening easier to implement as well as possible in nonclinical settings. This review will discuss new approaches to specimen collection and how these have expanded opportunities for reaching target populations for chlamydia screening. Furthermore, it will discuss how advanced molecular microbiological methods can be used with self-collected specimens to further our knowledge of the epidemiology of chlamydia and the dynamics of transmission.

Original languageEnglish
Pages (from-to)367-386
Number of pages20
JournalFuture Microbiology
Issue number3
Publication statusPublished - Mar 2013
Externally publishedYes


  • Chlamydia trachomatis
  • NAAT
  • organism load
  • point-of-care
  • screening
  • self-collected specimen
  • serovar
  • sexually transmitted infection
  • testing


Dive into the research topics of 'Advances in sampling and screening for chlamydia'. Together they form a unique fingerprint.

Cite this